In a decision underscoring the distinct standards governing enablement under §§ 102 and 112, the US Court of Appeals for the Federal Circuit affirmed the Patent Trial & Appeal Board’s finding that a prior art reference was...more
6/19/2025
/ Alice/Mayo ,
Appeals ,
CAFC ,
CRISPR ,
Life Sciences ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Prior Art ,
Section 101 ,
Summary Judgment
The US Court of Appeals for the Federal Circuit affirmed the Patent Trial & Appeal Board’s rejection of a proposed reissue claim for being broader than the original claim, denying the inventors’ argument that the analysis...more
The US Court of Appeals for the Federal Circuit affirmed the grant of a preliminary injunction (PI) in the biopharmaceutical space, concluding that the plaintiff satisfied the requirements for injunctive relief, including...more
7/26/2024
/ Appeals ,
Clinical Trials ,
Diagnostic Method ,
Enforcement ,
Infringement ,
Injunctive Relief ,
Irreparable Harm ,
Patents ,
Preliminary Injunctions ,
Prior Art ,
Research and Development